Fredun Pharmaceuticals Limited announced a private placement of 62,996 common shares at a price of INR 996.20 per share for proceeds of INR 62,756,615.2 to certain non-promoter entities; 37,140, each warrant convertible into 1 equity share of face value of INR 10; and 2,22,752 warrants at a price of INR 996.20 per warrant for proceeds of INR 221,905,542.4, each warrant, convertible into 1 Equity Share of face value of INR 10 each to certain non-promoters, on a preferential basis for total proceeds of INR 284,662,157.6 on August 27, 2022. The transaction has been approved by the board of directors of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
923.6 INR | -2.38% |
|
-1.05% | +6.31% |
05-10 | Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24 | CI |
05-08 | Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9% | MT |
1st Jan change | Capi. | |
---|---|---|
+6.31% | 51.93M | |
+51.63% | 796B | |
+41.51% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.66% | 244B | |
+3.39% | 228B | |
+10.75% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- FREDUN6 Stock
- News Fredun Pharmaceuticals Limited
- Fredun Pharmaceuticals Limited announced that it expects to receive INR 284.662157 million in funding